Syntara shows encouraging first signals it can impact the path to Parkinson's
Syntara (ASX:SNT) has reported encouraging interim results from its Phase 2 study of SNT-4728, providing the first clinical evidence that the company’s novel anti-inflammatory therapy may be targeting a key biological process linked to the development of Parkinson’...
Market Cap $518.7M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
| MMI | Mining Commences at Bauxite Hills | PRICE SENSITIVE | 16/04/18 | |
| MMI | Bauxite Hills Mine Preparing for Tropical Cyclone Nora | PRICE SENSITIVE | 23/03/18 | |
| MMI | S&P DJ Indices Announces March Quarterly Rebalance | PRICE SENSITIVE | 09/03/18 | |
| MMI | Bauxite Hills BFS Confirms Excellent Financial Returns | PRICE SENSITIVE | 15/03/17 | |
| MMI Mining Commences at Bauxite Hills | |||
| 16/04/18 | PRICE SENSITIVE | ||
| MMI Bauxite Hills Mine Preparing for Tropical Cyclone Nora | |||
| 23/03/18 | PRICE SENSITIVE | ||
| MMI S&P DJ Indices Announces March Quarterly Rebalance | |||
| 09/03/18 | PRICE SENSITIVE | ||
| MMI Bauxite Hills BFS Confirms Excellent Financial Returns | |||
| 15/03/17 | PRICE SENSITIVE | ||
